These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25445956)

  • 1. Oral immunization with recombinant hepatitis E virus antigen displayed on the Lactococcus lactis surface enhances ORF2-specific mucosal and systemic immune responses in mice.
    Gao S; Li D; Liu Y; Zha E; Zhou T; Yue X
    Int Immunopharmacol; 2015 Jan; 24(1):140-5. PubMed ID: 25445956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
    Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
    Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses.
    Song S; Li P; Zhang R; Chen J; Lan J; Lin S; Guo G; Xie Z; Jiang S
    Vaccine; 2019 Jul; 37(31):4364-4369. PubMed ID: 31227355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin.
    Gao Y; Su Q; Yi Y; Jia Z; Wang H; Lu X; Qiu F; Bi S
    PLoS One; 2015; 10(4):e0123400. PubMed ID: 25875115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal and systemic immunity in mice after intranasal immunization with recombinant Lactococcus lactis expressing ORF6 of PRRSV.
    Wang ZH; Cao XH; Du XG; Feng HB; Di-Wang ; He-Song ; Zeng XY
    Cell Immunol; 2014 Feb; 287(2):69-73. PubMed ID: 24423464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination.
    Zhang Q; Zhong J; Huan L
    Microbiol Res; 2011 Feb; 166(2):111-20. PubMed ID: 20227266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses.
    Wang Z; Gao J; Yu Q; Yang Q
    Future Microbiol; 2012 Aug; 7(8):1003-10. PubMed ID: 22913358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with r-Lactococcus lactis expressing outer membrane protein A of Shigella dysenteriae type-1: evaluation of oral and intranasal route of administration.
    Yagnik B; Sharma D; Padh H; Desai P
    J Appl Microbiol; 2017 Feb; 122(2):493-505. PubMed ID: 27860045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.
    Huang WJ; Zhang HY; Harrison TJ; Lan HY; Huang GY; Wang YC
    Arch Virol; 2009; 154(3):481-8. PubMed ID: 19240977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of immune responses to hepatitis E virus ORF2 DNA vaccination by codelivery of cytokine genes.
    Tuteja R; Li TC; Takeda N; Jameel S
    Viral Immunol; 2000; 13(2):169-78. PubMed ID: 10892997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization.
    Ahmed B; Loos M; Vanrompay D; Cox E
    Vaccine; 2014 Jun; 32(31):3909-16. PubMed ID: 24877767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis.
    Torkashvand A; Bahrami F; Adib M; Ajdary S
    Microb Pathog; 2018 Jul; 120():155-160. PubMed ID: 29738814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
    Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
    Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.
    Arankalle VA; Lole KS; Deshmukh TM; Srivastava S; Shaligram US
    Vaccine; 2009 Feb; 27(7):1032-9. PubMed ID: 19095027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein.
    Taghinezhad-S S; Mohseni AH; Keyvani H; Razavilar V
    Microb Pathog; 2019 Jan; 126():149-156. PubMed ID: 30391536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.
    Chamcha V; Jones A; Quigley BR; Scott JR; Amara RR
    J Immunol; 2015 Nov; 195(10):5025-34. PubMed ID: 26482408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live recombinant Lactococcuslactis expressing avian hepatitis virus ORF2 protein: Immunoprotection against homologous virus challenge in chickens.
    Wang D; Zhang Y; Ma C; Ma D; Zhao Q; Wang F; Huang Y; Li J; Zhang L; Zhou EM
    Vaccine; 2018 Feb; 36(8):1108-1115. PubMed ID: 29406242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.
    Sáez D; Fernández P; Rivera A; Andrews E; Oñate A
    Vaccine; 2012 Feb; 30(7):1283-90. PubMed ID: 22222868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.
    Sanford BJ; Opriessnig T; Kenney SP; Dryman BA; Córdoba L; Meng XJ
    Vaccine; 2012 Sep; 30(44):6249-55. PubMed ID: 22906724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.